Perrigo Company plc Proceeds from Divestiture of Businesses
Perrigo Company plc (PRGO) reported Proceeds from Divestiture of Businesses of $362.90 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2026-08-05
- Perrigo Company plc proceeds from divestiture of businesses for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc proceeds from divestiture of businesses for the quarter ending 2025-09-27 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc proceeds from divestiture of businesses for the quarter ending 2024-12-31 was $10.00M.
- Perrigo Company plc proceeds from divestiture of businesses for the quarter ending 2024-09-28 was $205.50M.
- Perrigo Company plc proceeds from divestiture of businesses for fiscal 2025 was $14.40M, a 93.32% decline from fiscal 2024.
- Perrigo Company plc proceeds from divestiture of businesses for fiscal 2024 was $215.50M.
- Perrigo Company plc proceeds from divestiture of businesses for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Perrigo Company plc proceeds from divestiture of businesses for fiscal 2022 was $58.70M, a 96.07% decline from fiscal 2021.
| Period end | Proceeds from Divestiture of Businesses | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 9 month as first filed | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-27 | $362.90M 10-Q · filed 2026-08-05 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $14.40M 10-K · filed 2026-02-26 | |||
| 2025-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.40M 10-Q · filed 2025-11-05 | ||||
| 2025-06-28 | $14.40M 10-Q · filed 2026-08-05 | |||||
| 2024-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $215.50M derived: sum of 2 quarters · filed 2026-02-26 | $215.50M 10-K · filed 2026-02-26 | |||
| 2024-09-28 | $205.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $205.50M 10-Q · filed 2025-11-05 | ||||
| 2024-06-29 | $0.00 10-Q · filed 2025-08-06 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-04-01 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $58.70M 10-K · filed 2025-02-28 | ||
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $58.70M 10-Q · filed 2023-11-07 | $57.50M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $58.70M 10-Q · filed 2023-08-08 | $57.50M derived: sum of 3 quarters · filed 2024-02-27 | $1.55B derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-04-02 | $58.70M 10-Q · filed 2023-05-09 | $57.50M derived: sum of 2 quarters · filed 2024-02-27 | $1.55B derived: sum of 3 quarters · filed 2024-02-27 | $1.55B derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.49B derived: sum of 2 quarters · filed 2024-02-27 | $1.49B derived: sum of 3 quarters · filed 2024-02-27 | $1.49B 10-K · filed 2024-02-27 | ||
| 2021-10-02 | $1.49B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.49B derived: sum of 2 quarters · filed 2022-11-08 | $1.49B 10-Q · filed 2022-11-08 | $1.49B derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-04-03 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $187.80M 10-K · filed 2023-02-28 | |||
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $187.80M 10-Q · filed 2021-11-12 | ||||
| 2020-06-27 | $187.80M 10-Q · filed 2021-08-11 | |||||
| 2019-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $182.50M derived: sum of 2 quarters · filed 2022-03-01 | $182.50M derived: sum of 3 quarters · filed 2022-03-01 | $182.50M 10-K · filed 2022-03-01 | ||
| 2019-09-28 | $183.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $183.40M derived: sum of 2 quarters · filed 2020-11-05 | $183.40M 10-Q · filed 2020-11-05 | $188.60M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-07-08 | $185.00M 10-Q · filed 2019-11-06 | |||||
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $5.20M derived: sum of 3 quarters · filed 2021-03-01 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-30 | $0.00 10-Q · filed 2019-05-09 | $5.20M derived: sum of 2 quarters · filed 2021-03-01 | $3.90M derived: sum of 3 quarters · filed 2021-03-01 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.90M derived: sum of 2 quarters · filed 2021-03-01 | $3.90M derived: sum of 3 quarters · filed 2021-03-01 | $5.20M 10-K · filed 2021-03-01 | ||
| 2018-09-29 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$1.30M derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $5.00M 10-Q · filed 2018-11-08 | $107.90M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.30M 10-Q · filed 2019-08-08 | $109.20M derived: sum of 3 quarters · filed 2020-02-27 | $118.70M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $1.30M 10-Q · filed 2019-05-09 | $109.20M derived: sum of 2 quarters · filed 2020-02-27 | $118.70M derived: sum of 3 quarters · filed 2020-02-27 | $130.60M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $107.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $117.40M derived: sum of 2 quarters · filed 2020-02-27 | $129.30M derived: sum of 3 quarters · filed 2020-02-27 | $154.60M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $21.40M derived: sum of 2 quarters · filed 2018-11-08 | $46.70M 10-Q · filed 2018-11-08 | $57.30M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-07-01 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $37.20M 10-Q · filed 2018-08-09 | $47.80M derived: sum of 3 quarters · filed 2019-02-27 | $106.30M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-04-01 | $25.30M 10-Q · filed 2018-05-08 | $35.90M derived: sum of 2 quarters · filed 2019-02-27 | $94.40M derived: sum of 3 quarters · filed 2019-02-27 | $94.40M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-02-01 | $7.70M 10-Q · filed 2017-05-30 | |||||
| 2016-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $69.10M derived: sum of 2 quarters · filed 2019-02-27 | $69.10M derived: sum of 3 quarters · filed 2019-02-27 | $69.10M 10-K · filed 2019-02-27 | ||
| 2016-10-01 | $58.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $58.50M derived: sum of 2 quarters · filed 2017-11-09 | $58.50M 10-Q · filed 2017-11-09 | |||
| 2016-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $0.00 10-Q · filed 2017-08-10 | ||||
| 2016-04-02 | $0.00 10-Q · filed 2017-05-30 | |||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 | |||||
| 2015-09-26 | $0.00 10-Q/A · filed 2017-05-23 | |||||
| 2015-06-27 | $0.00 10-K · filed 2018-03-01 | |||||
| 2014-09-27 | $1.10M 8-K · filed 2014-11-20 | |||||
| 2014-06-28 | $0.00 10-K · filed 2017-05-22 | |||||
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |